Private Advisor Group LLC raised its position in Intrexon Corporation (NYSE:XON) by 9.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,026 shares of the biotechnology company’s stock after acquiring an additional 3,524 shares during the quarter. Private Advisor Group LLC’s holdings in Intrexon Corporation were worth $917,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in Intrexon Corporation by 5.6% in the first quarter. Vanguard Group Inc. now owns 4,286,362 shares of the biotechnology company’s stock valued at $84,954,000 after acquiring an additional 226,090 shares during the period. Iridian Asset Management LLC CT lifted its holdings in Intrexon Corporation by 2.4% in the first quarter. Iridian Asset Management LLC CT now owns 3,853,274 shares of the biotechnology company’s stock valued at $76,372,000 after acquiring an additional 91,565 shares during the period. State Street Corp lifted its holdings in Intrexon Corporation by 34.0% in the first quarter. State Street Corp now owns 2,707,242 shares of the biotechnology company’s stock valued at $53,664,000 after acquiring an additional 687,406 shares during the period. First Trust Advisors LP lifted its holdings in Intrexon Corporation by 32.5% in the second quarter. First Trust Advisors LP now owns 1,537,088 shares of the biotechnology company’s stock valued at $37,028,000 after acquiring an additional 376,780 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Intrexon Corporation by 3.5% in the first quarter. Geode Capital Management LLC now owns 429,532 shares of the biotechnology company’s stock valued at $8,513,000 after acquiring an additional 14,674 shares during the period. 82.27% of the stock is currently owned by institutional investors.
A number of research firms have weighed in on XON. Zacks Investment Research downgraded Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. BidaskClub raised Intrexon Corporation from a “strong sell” rating to a “sell” rating in a report on Thursday, June 15th. Finally, Northland Securities set a $30.00 target price on Intrexon Corporation and gave the company a “buy” rating in a report on Monday, August 7th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. Intrexon Corporation presently has a consensus rating of “Hold” and a consensus price target of $37.60.
In related news, Director Robert B. Shapiro bought 2,850 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were purchased at an average price of $17.50 per share, for a total transaction of $49,875.00. Following the completion of the purchase, the director now directly owns 43,157 shares of the company’s stock, valued at $755,247.50. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Dean J. Mitchell bought 5,000 shares of the stock in a transaction dated Friday, August 11th. The stock was bought at an average price of $18.33 per share, for a total transaction of $91,650.00. Following the purchase, the director now directly owns 18,103 shares of the company’s stock, valued at $331,827.99. The disclosure for this purchase can be found here. Insiders bought 144,569 shares of company stock worth $2,719,429 in the last 90 days. Company insiders own 56.30% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Private Advisor Group LLC Purchases 3,524 Shares of Intrexon Corporation (XON)” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/09/12/private-advisor-group-llc-purchases-3524-shares-of-intrexon-corporation-xon.html.
Intrexon Corporation (NYSE XON) opened at 19.85 on Tuesday. The company’s market cap is $2.39 billion. Intrexon Corporation has a 1-year low of $17.03 and a 1-year high of $32.90. The stock has a 50 day moving average price of $19.96 and a 200 day moving average price of $21.50.
Intrexon Corporation (NYSE:XON) last issued its earnings results on Wednesday, August 9th. The biotechnology company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.05. Intrexon Corporation had a negative return on equity of 19.08% and a negative net margin of 60.63%. The firm had revenue of $54.40 million for the quarter, compared to the consensus estimate of $57.17 million. During the same quarter in the prior year, the business earned ($0.42) earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts anticipate that Intrexon Corporation will post ($0.87) EPS for the current fiscal year.
Intrexon Corporation Profile
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).
Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.